India's Indraprastha Medical extends fall after allegations of illegal kidney transplants

Indraprastha Medical

06/12/2023 05:13

** Shares of Indraprastha Medical Corporation  IMCL.NS 
extend losses from the previous session to trade down as much as
5% at 189.95 rupees
    ** IMCL, which manages two Apollo  APLH.NS  hospitals in
Delhi, denied allegations of its involvement in illegal kidney
transplants
    ** Britain's The Telegraph newspaper said over the weekend
Apollo Hospitals Group was enticing young villagers from Myanmar
to their Delhi hospital to sell their kidneys to rich patients
around the world
    ** IMCL says has initiated inquiry into all aspects of the
transplant process
    ** More than 245,000 shares change hands, 1.7x their 30-day
avg
    ** APLH last down 0.3%; IMCL shares have more than doubled
YTD, while APLH has risen 24%

 (Reporting by Rama Venkat in Bengaluru)
 ((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))